Thursday, February 21, 2019
News

Alembic Pharma gets tentative USFDA nod for Ticagrelor tablets

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Mumbai | Thursday, Jul 12 2018 IST
Pharma Major, Alembic Pharmaceuticals said that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abberivated New Drug Application(ANDA) Ticagrelor tablets 90 mg.

The tentatively approved Abbreviated New Drug Application (ANDA) is therapeutically equivalent to the reference listed drug product (RLD), Brilinta tablets of Astrazeneca Pharmaceuticals LP.

It is used to reduce the rate of cardiovascular death and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI).

Quoting IQVIA sales data, the company said, Ticagrelor tablets, 90 mg had an estimated market size of USD625 million for 12 months, ending December 2017.

The company said it now has a total of 75 ANDA approvals from the USFDA.

UNI JS NV SM SDR 1440

-- (UNI) -- C-1-DL0171-1435611.Xml

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Cong wont form govt at Centre, will con...
18 separatists, 155 J&K politicians lose...
Shimla: Snowfall in Kufri, Chharabra dis...
BJP politicising Pulwama terror attack: ...
Amit Shah to launch BJPs beneficiaries ...
J-K: Community bunkers being made forsa...
More...    
 
 Top Stories
Fresh snowfall, landslides shut Jam... 
Committed to 'free, open Indo-Pacif... 
Fire kills 69 in Bangladesh capital... 
Aurangabad Petrol pumps shut down t... 
Hormonal changes are ruining my lif... 
Guaido, US military leader push Ven... 
Differently-abled senior citizen bu... 
At Lucknow cafe, special kids help ...